Latest ITCI reports update at 2024-05-07: 2024-Q12023-Q42023-Q1
Intra-Cellular Therapies logo
Intra-Cellular Therapies ITCI
$ 69.56 0.71%

Intra-Cellular Therapies Operating Cash Flow 2011-2024 | ITCI

Annual Operating Cash Flow Intra-Cellular Therapies

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-124 M -270 M -260 M -230 M -128 M -118 M -80.5 M -91.3 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-80.5 M -270 M -163 M

Quarterly Operating Cash Flow Intra-Cellular Therapies

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-34.1 M - - - -60.1 M - -231 M -178 M -82.8 M - -186 M -107 M -47.8 M - -162 M -98.3 M -51.2 M - -92.9 M -62.9 M -35.6 M - -89 M -60.6 M -27 M - -55.7 M -41.3 M - - - - - - - - - - - - - - - -9.92 K - - -14.8 M - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-9.92 K -231 M -81.8 M